In 2024, the global market size of Osteoporosis Drugs was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include th...
In 2024, the global market size of Biosimilar Drug was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from...
In 2024, the global market size of Avian Influenza Vaccines was estimated to be worth US$ 1100 million and is forecast to reach approximately US$ 1592 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide an...
In 2024, the global market size of Anti-Peptic Ulcer Drugs was estimated to be worth US$ 11180 million and is forecast to reach approximately US$ 26650 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tra...
In 2024, the global market size of Liraglutide was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed u...
In 2024, the global market size of Remifentanil Hydrochloride was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesi...
In 2024, the global market size of Moxifloxacin HCl was estimated to be worth US$ 116 million and is forecast to reach approximately US$ 110 million by 2031 with a CAGR of -0.8% during the forecast period 2025-2031.
Moxifloxacin hydrochloride (moxifloxacin HCl) is used to treat a variety of bacterial infections. Moxifloxacin HCl is a broad-spectrum fourth generation fluoroquinolone antibiotic. The...
In 2024, the global market size of Meningococcal Vaccine was estimated to be worth US$ 285 million and is forecast to reach approximately US$ 384 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They...
In 2024, the global market size of Natamycin was estimated to be worth US$ 210 million and is forecast to reach approximately US$ 323 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the gro...
In 2024, the global market size of Contract Pharmaceutical Manufacturing was estimated to be worth US$ 97880 million and is forecast to reach approximately US$ 145390 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production,...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals